ClinicalTrials.gg
CompletedNCT04800354Updated Jan 11, 2022

Brief Nurse-led Mindfulness Based Intervention

An interventional study of Nurse-led Mindfulness Based Intervention and Nurse-led Pain Psychoeducation in Pain, Osteoarthritis, Knee and Osteoarthritis, Hip, sponsored by University of Utah. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-11.

Sponsored by University of Utah · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
127
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a single-site, two-arm, parallel-group randomized clinical trial (RCT). The feasibility, acceptability, and clinical effects of the nurse-led, very brief, preoperative mindfulness based intervention for hip and knee replacement patients will be investigated relative to nurse-led preoperative pain psychoeducation.

A secondary sub-analysis will compare two different styles of mindfulness practice (mindfulness of breath vs. mindfulness of pain) relative to preoperative pain psychoeducation.

02

Conditions studied

  • Pain
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's enrollment of 127 is above the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

University of Utah is the lead sponsor of 991 studies on the registry; 177 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 64 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1) Age ≥18,
  • 2) Scheduled to undergo unilateral total knee arthroplasty

Exclusion criteria

Exclusion Criteria:

  • 1) Cognitive impairment preventing completion of study procedures.
  • 2) Current cancer diagnosis,
  • 3) Contralateral knee replaced in the previous 3 months,
  • 4) Intent to have contralateral knee replaced or other, additional surgical procedure during the study period,
  • 5) Intent to add new pain treatments during the study period (except for what is part of the study),
  • 6) Other unstable illness judged by medical staff to interfere with study treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
127 participants (actual)

Study arms

  • Experimental
    Nurse-led Mindfulness Based Intervention

    Behavioral: Nurse-led Mindfulness Based Intervention · Behavioral: Nurse-led Pain Psychoeducation

  • Active comparator
    Nurse-led Pain Psychoeducation

    Behavioral: Nurse-led Pain Psychoeducation

Interventions

  • BehavioralNurse-led Mindfulness Based Intervention

    Nurses will read patients a brief (1 minute) scripted, introduction to mindfulness and then have them listen to a very brief (1 minute 30 second) guided mindfulness practice validated in our prior research to encourage focused attention on breath and body sensations and open monitoring and acceptance of discursive thoughts, negative emotions, and pain. Finally, patients will be given an audio recording of the mindful pain management technique for use any time they experience intense pain or take pain medication before and after surgery.

  • BehavioralNurse-led Pain Psychoeducation

    Nurses will provide psychoeducation about pain along with common pain coping strategies, such as rest, ice, and elevation, for use any time they experience intense pain or take pain medication before and after surgery.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity Numeric Rating Scale

    Single Likert scale item ranging from 0-10, with 0 indicating no pain and 10 representing the most intense pain imaginable.

    Time frame: baseline and after the 15 minute preoperative nurse visit

Secondary outcomes

  1. Change in Pain Unpleasantness Numeric Rating Scale

    Single Likert scale item ranging from 0-10, with 0 indicating no pain and 10 representing the most unpleasant pain imaginable.

    Time frame: baseline and after the 15 minute preoperative nurse visit

  2. Change in Pain Medication Desire Numeric Rating Scale

    Single Likert scale item ranging from 0-10, with 0 indicating no desire for pain medication and 10 representing a strong desire for pain medication.

    Time frame: baseline and after the 15 minute preoperative nurse visit

  3. Postoperative Patient Reported Outcomes Measurement Information System (PROMIS) Physical Functioning Item Bank, v2.0

    The PROMIS physical functioning computer assisted test draws from a bank of 123 items all scored on a 5 point Likert scale. T-Score distributions are standardized such that a 50 represents the average (mean) for the US general population, and the standard deviation around that mean is 10 points. A high score better physical functioning.

    Time frame: During the 6 weeks prior to surgery and at the 6-week outpatient follow-up appointment

07

Study locations

1 site
  • University of Utah
    Salt Lake City, Utah 84112, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2021 to primary completion in May 2021, 2 months.

Of 1,253 non-industry interventional studies with no phase under Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 29. This study's 2 months is below that.

Counting every sponsor, half of 1,276 studies reached it within 11 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2021
First posted
Mar 16, 2021
StartActual
Feb 22, 2021
Primary completionActual
May 20, 2021
CompletionActual
Jan 10, 2022
Last update
Jan 11, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04800354
Lead sponsor
University of Utah
Responsible party
Adam Hanley (Assistant Professor, University of Utah) — Principal investigator
First posted
Mar 16, 2021
Start date
Feb 22, 2021
Primary completion
May 20, 2021
Completion
Jan 10, 2022
Last update
Jan 11, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion